[Other] MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer

tns Post time 2024-6-5 08:40:50 | Show all posts |Read mode
Reward20points

journal:Future Oncology

Authors:Byoung Chul Cho; Enriqueta Felip; Hidetoshi Hayashi; Michael Thomas; Shun Lu; Benjamin Besse; Tao Sun; Melissa Martinez; Seema N Sethi; S Martin Shreeve; Alexander I Spira

Published date:2022-2-

DOI:10.2217/fon-2021-0923

PDF link:https://www.tandfonline.com/doi/pdf/10.2217/fon-2021-0923

Article link:http://dx.doi.org/10.2217/fon-2021-0923

Article Source:Informa UK Limited


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
bitzkyboy Post time 2024-6-5 08:40:51 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    130

Latest Reply

Return to the list